SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand May 13, 2026 by wealthalpha Other news SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand Source link Previous News Bitcoin back above $81,000 after hot CPI print, BNB, DOGE lead majors gains Next News Bharti Airtel share price: Should you buy telecom stock ahead of Q4 results? wealthalpha
Leave A Comment